Fiduciary Scrutiny Over Board Discretion In Private Mergers
Board discretion in private mergers is constrained by fiduciary duties when consideration allocation conflicts with preferred liquidation preferences.
corwin doctrine
Meaning
An affirmative defense in corporate law clears director liability for breach of fiduciary duty when a fully informed, uncoerced vote of disinterested stockholders approves a transaction. Under the corwin doctrine, the approval of a merger by uncoerced shareholders restores the protective business judgment rule. This legal framework shifts standard judicial review away from heightened scrutiny to a deferential standard.
The doctrine applies to post-closing damages claims against directors, but it does not protect controller transactions that involve self-dealing or squeeze-out mergers.
Judicial Standard
Transaction disputes often subject board decisions to intrusive review when conflicts arise between founders and external investors. Invoking the corwin doctrine lowers the standard of review to business judgment, making post-closing damages lawsuits subject to dismissal. This shift protects selling directors from protracted litigation after closing a corporate transaction.
Disclosure Requirement
Stockholder approval cleanses fiduciary breaches only if the proxy materials contain accurate details. Applying the corwin doctrine requires complete transparency regarding executive compensation and board conflicts. Omitted facts or misleading statements invalidate the stockholder vote, leaving directors exposed to breach of care claims.
Legal counsel must draft transaction disclosures with rigorous precision to ensure that shareholders receive material facts. The board carries the burden of proving that the voting process was uncoerced and fully informed. When founders receive side benefits, such as commercial agreements or roll-over equity, these arrangements require explicit disclosure.
Inadequate proxy statements forfeit judicial deference and expose former executives to financial liability.
Director Immunity
Clean shareholder approval provides former officers and directors with protection against post-sale litigation costs. Reaching this safe harbor preserves personal capital and executive reputation following a sale. Without stockholder cleansing, fiduciary lawsuits consume considerable attention and legal expense during post-exit transitions.